Related references
Note: Only part of the references are listed.Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Neuroprotective Properties and Mechanisms of Resveratrol in in Vitro and in Vivo Experimental Cerebral Stroke Models
Nilendra Singh et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8
David Porquet et al.
AGE (2013)
Transcriptional Upregulation of Plasminogen Activator Inhibitor-1 in Rat Primary Astrocytes by a Proteasomal Inhibitor MG 132
Kyu Suk Cho et al.
BIOMOLECULES & THERAPEUTICS (2013)
Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases
Albino Carrizzo et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein
Atsushi Kuno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Resveratrol decreases inflammation in the brain of mice with mild traumatic brain injury
Joshua W. Gatson et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2013)
Glucose deprivation reversibly down-regulates tissue plasminogen activator via proteasomal degradation in rat primary astrocytes
Kyu Suk Cho et al.
LIFE SCIENCES (2013)
Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4′-tri-O-acetylresveratrol in rats
Li Liang et al.
PHYTOMEDICINE (2013)
Resveratrol Suppresses PAI-1 Gene Expression in a Human In Vitro Model of Inflamed Adipose Tissue
Ivana Zagotta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Impact of Manganese Neurotoxicity on MMP-9 Production and Superoxide Dismutase Activity in Rat Primary Astrocytes. Effect of Resveratrol and Therapeutical Implications for the Treatment of CNS Diseases
Tiziana Latronico et al.
TOXICOLOGICAL SCIENCES (2013)
Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2
Zhen Li et al.
BRAIN RESEARCH (2012)
Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors
David Pineda et al.
GLIA (2012)
Resveratrol Reduces Matrix Metalloproteinase-2 Activity Induced by Oxygen-Glucose Deprivation and Reoxygenation in Human Cerebral Microvascular Endothelial Cells
Zahide Cavdar et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2012)
Anti-inflammatory Effects of Resveratrol and Its Potential Use in Therapy of Immune-mediated Diseases
Urban Svajger et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Resveratrol mitigates lipopolysaccharide- and Aß-mediated microglial inflammation by inhibiting the TLR4/NF-?B/STAT signaling cascade
Hemachander Capiralla et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain
Dipti V. Tillu et al.
MOLECULAR PAIN (2012)
Key contribution of CPEB4-mediated translational control to cancer progression
Elena Ortiz-Zapater et al.
NATURE MEDICINE (2012)
tPA in the injured central nervous system: different scenarios starring the same actor?
Sighild Lemarchant et al.
NEUROPHARMACOLOGY (2012)
Resveratrol as a calorie restriction mimetic: therapeutic implications
Jay H. Chung et al.
TRENDS IN CELL BIOLOGY (2012)
Resveratrol and cellular mechanisms of cancer prevention
Yogeshwer Shukla et al.
RESVERATROL AND HEALTH (2011)
Resveratrol and life extension
Beamon Agarwal et al.
RESVERATROL AND HEALTH (2011)
Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain
Filippos Karalis et al.
BRAIN RESEARCH (2011)
Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
Shuang Zhou et al.
CIRCULATION RESEARCH (2011)
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
V. Foti Cuzzola et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Ischemic insult induced apoptotic changes in PC12 cells: Protection by trans resveratrol
Megha Agrawal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells
Soo-Jin Lee et al.
LIFE SCIENCES (2011)
Resveratrol Pretreatment Attenuates Cerebral Ischemic Injury by Upregulating Expression of Transcription Factor Nrf2 and HO-1 in Rats
Junwei Ren et al.
NEUROCHEMICAL RESEARCH (2011)
Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: Essential role of astrocyte-derived plasminogen activator inhibitor-1
Ji Woon Kim et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK
Mayur I. Patel et al.
PHARMACOLOGICAL REPORTS (2011)
Neuroprotective properties of resveratrol in different neurodegenerative disorders
Diego Albani et al.
BIOFACTORS (2010)
Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1
Yoshihito Sakata et al.
EXPERIMENTAL NEUROLOGY (2010)
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Valerie Vingtdeux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
Ali Reza A. Ladiwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures
Amanda J. Meade et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Resveratrol Attenuates Behavioral Impairments and Reduces Cortical and Hippocampal Loss in a Rat Controlled Cortical Impact Model of Traumatic Brain Injury
Richard H. Singleton et al.
JOURNAL OF NEUROTRAUMA (2010)
Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Albert Y. Sun et al.
MOLECULAR NEUROBIOLOGY (2010)
Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats
Chao Li et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Combination Treatment With VELCADE and Low-Dose Tissue Plasminogen Activator Provides Potent Neuroprotection in Aged Rats After Embolic Focal Ischemia
Li Zhang et al.
STROKE (2010)
Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia
Seema Yousuf et al.
BRAIN RESEARCH (2009)
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
Saravanan S. Karuppagounder et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Resveratrol inhibits MMP-9 expression by up-regulating PPAR α expression in an oxygen glucose deprivation-exposed neuron model
Gang Cheng et al.
NEUROSCIENCE LETTERS (2009)
Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
Rao Muralikrishna Adibhatla et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures
Lucia Maria Vieira de Almeida et al.
NEUROCHEMICAL RESEARCH (2008)
Inhibition of caspases and intracellular free Ca2+ concentrations are involved in resveratrol protection against apoptosis in rat primary neuron cultures
Qi-hai Gong et al.
ACTA PHARMACOLOGICA SINICA (2007)
Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures
Lucia Maria Vieira de Almeida et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neuroprotection by resveratrol against traumatic brain injury in rats
Ozkan Ates et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
The mTOR pathway in the control of protein synthesis
Xuemin Wang et al.
PHYSIOLOGY (2006)
Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells
Andre Quincozes dos Santos et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways
Arianna L. Kim et al.
EXPERIMENTAL DERMATOLOGY (2006)
Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice
DK Gao et al.
LIFE SCIENCES (2006)
Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity
Andre L. Samson et al.
NEURON (2006)
The roles of polyphenols in cancer chemoprevention
Ki Won Lee et al.
BIOFACTORS (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
The neurotoxicity of tissue plasminogen activator?
J Kaur et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia
SA Andrabi et al.
BRAIN RESEARCH (2004)
Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator
N Mataga et al.
NEURON (2004)
Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation
CY Shin et al.
JOURNAL OF NEUROSCIENCE (2004)
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
O Nicole et al.
NATURE MEDICINE (2001)
Share Paper
